MGC Pharma to acquire Israel based MediCaNL for $6.0 million in shares

LONDON: MGC Pharmaceuticals Ltd announced the acquisition of 100% of the issued share capital of MediCaNL Inc. MediCaNL Inc is the holding company of MediCaNL Israel 2019 Ltd, an Israeli…

NNR April 22, 2021

Wire

UK begins clinical trials of Covid-busting nasal spray

LONDON: The first UK clinical trials of a nasal spray proven to kill 99.9% of the coronavirus that causes Covid-19 will begin on January 11th at Ashford and St Peter’s…

NNR January 11, 2021

Australian Exchange

AstraZeneca selects ImpediMed’s SOZO devices for upcoming clinical trials

BRISBANE: ImpediMed Limited announced a second contract valued at over $2.0 million for its SOZO Digital Health Platform to be used in a clinical trial being conducted for AstraZeneca, a…

NNR November 9, 2020

London Exchange

AstraZeneca’s COVID-19 long-acting antibody combination advances into Phase III clinical trials

US Government to invest ~$486m for development and supply of up to 100,000 doses and can acquire another one million doses LONDON: AstraZeneca's long-acting antibody (LAAB) combination, AZD7442, will advance…

NNR October 12, 2020